OtherClinical Investigations
Assessment of Malignant Skeletal Disease: Initial Experience with 18F-Fluoride PET/CT and Comparison Between 18F-Fluoride PET and 18F-Fluoride PET/CT
Einat Even-Sapir, Ur Metser, Gideon Flusser, Limor Zuriel, Yehuda Kollender, Hedva Lerman, Gennady Lievshitz, Ilan Ron and Eyal Mishani
Journal of Nuclear Medicine February 2004, 45 (2) 272-278;
Einat Even-Sapir
Ur Metser
Gideon Flusser
Limor Zuriel
Yehuda Kollender
Hedva Lerman
Gennady Lievshitz
Ilan Ron
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Assessment of Malignant Skeletal Disease: Initial Experience with 18F-Fluoride PET/CT and Comparison Between 18F-Fluoride PET and 18F-Fluoride PET/CT
Einat Even-Sapir, Ur Metser, Gideon Flusser, Limor Zuriel, Yehuda Kollender, Hedva Lerman, Gennady Lievshitz, Ilan Ron, Eyal Mishani
Journal of Nuclear Medicine Feb 2004, 45 (2) 272-278;
Assessment of Malignant Skeletal Disease: Initial Experience with 18F-Fluoride PET/CT and Comparison Between 18F-Fluoride PET and 18F-Fluoride PET/CT
Einat Even-Sapir, Ur Metser, Gideon Flusser, Limor Zuriel, Yehuda Kollender, Hedva Lerman, Gennady Lievshitz, Ilan Ron, Eyal Mishani
Journal of Nuclear Medicine Feb 2004, 45 (2) 272-278;
Related Articles
- No related articles found.
Cited By...
- Molecular Imaging of Bone Metastases and Their Response to Therapy
- Comparison of the Variability of SUV Normalized by Skeletal Volume with the Variability of SUV Normalized by Body Weight in 18F-Fluoride PET/CT
- The Utility of PET/CT in the Planning of External Radiation Therapy for Prostate Cancer
- The Role of 18F-Sodium Fluoride PET/CT Bone Scans in the Diagnosis of Metastatic Bone Disease from Breast and Prostate Cancer
- What Medical, Urologic, and Radiation Oncologists Want from Molecular Imaging of Prostate Cancer
- Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment
- 18F-Fluoride PET in the Assessment of Malignant Bone Disease
- Multimodal Partial-Volume Correction: Application to 18F-Fluoride PET/CT Bone Metastases Studies
- Semiquantitative Analysis of the Biodistribution of the Combined 18F-NaF and 18F-FDG Administration for PET/CT Imaging
- Evaluation of 18F-Fluoride PET/MR and PET/CT in Patients with Foot Pain of Unclear Cause
- Quantification of 18F-Fluoride Kinetics: Evaluation of Simplified Methods
- PET/MR in Oncology: Non-18F-FDG Tracers for Routine Applications
- Combined 18F-Fluoride and 18F-FDG PET/CT Scanning for Evaluation of Malignancy: Results of an International Multicenter Trial
- Utility of 18F-Fluoride PET/CT and 18F-FDG PET/CT in the Detection of Bony Metastases in Heightened-Risk Head and Neck Cancer Patients
- Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies
- Small-Animal PET/CT Assessment of Bone Microdamage in Ovariectomized Rats
- SNM Practice Guideline for Sodium 18F-Fluoride PET/CT Bone Scans 1.0
- Assessment of Patient Exposure to X-Radiation from SPECT/CT Scanners
- The Role of Radiotracer Imaging in the Diagnosis and Management of Patients with Breast Cancer: Part 1--Overview, Detection, and Staging
- Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease
- Skeletal PET with 18F-Fluoride: Applying New Technology to an Old Tracer
- Can PET/CT Replace Separate Diagnostic CT for Cancer Imaging? Optimizing CT Protocols for Imaging Cancers of the Chest and Abdomen
- SPECT-Guided CT for Evaluating Foci of Increased Bone Metabolism Classified as Indeterminate on SPECT in Cancer Patients
- [18F]Fluorodeoxyglucose Positron Emission Tomography Is More Sensitive Than Skeletal Scintigraphy for Detecting Bone Metastasis in Endemic Nasopharyngeal Carcinoma at Initial Staging
- The Detection of Bone Metastases in Patients with High-Risk Prostate Cancer: 99mTc-MDP Planar Bone Scintigraphy, Single- and Multi-Field-of-View SPECT, 18F-Fluoride PET, and 18F-Fluoride PET/CT
- Whole body PET/CT for initial staging of choroidal melanoma
- Imaging of Malignant Bone Involvement by Morphologic, Scintigraphic, and Hybrid Modalities